(Photo by Drew Angerer/Getty Images)
Larry Richert and John Shumway
October 09, 2019 - 11:13 am
The Food and Drug Administration says third-party testing methods may be to blame for the high amount of carcinogens found in heart burn medicine, but a voluntary recall remains in place for ranitidine capsules, commonly sold as Zantac.
Read More